INR Advisory Services’s AstraZeneca AZN Stock Holding History

INR Advisory Services’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-47	Closed	-$3K	–	46
2018 Q2	$3K	Buy	+47	New	+$3.38K	﹤0.01%	53

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

INR Advisory Services's AZN Position: Q3 2018 in Review

INR Advisory Services sold out of AstraZeneca (AZN) in Q3 2018, closing a stake of 47 shares — an estimated $3K sold.

INR Advisory Services first reported a position in AZN in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 544 funds tracked by Wall St. Rank hold AZN as of Q3 2018.

INR Advisory Services reported no remaining AstraZeneca position as of Q3 2018 after selling out during the quarter.
INR Advisory Services sold 47 AstraZeneca shares in Q3 2018, an estimated $3K.
INR Advisory Services first reported a position in AstraZeneca in Q2 2018 and held it in 1 quarter.
INR Advisory Services's AstraZeneca position peaked at $3K in Q2 2018.
544 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2018.

Based on INR Advisory Services's 13F filing for Q3 2018, filed 5 Dec 2018.